About 5,000 women living with HIV in the U.S. give birth each year.
Research advances and programs and politics have reduced the annual number of HIV infections through perinatal transmission in the United States by more than 95% since the early ’90s. Every year, about 5,000 women living with HIV give birth in the U.S., according HIV.gov, the official HHS website for information on HIV/AIDS. In 2018, 35 infants were born with perinatal HIV infection in the U.S., according to HIV.gov.
“A pregnant woman who is living with HIV is at great risk of transmitting the virus to her unborn child if she doesn’t take the necessary precautions,” notes Rudolf Probst, M.D/, a professor at the Baylor College of Medicine. “The transmission is likely to happen during labor and delivery; however, when the baby is born, it can happen during breastfeeding.”
In places with limited resources, the World Health Organization and other groups encourage mothers infected with HIV to breastfeed and to take antiretroviral drugs to reduce the risk of transmission. In the United States, the CDC and the American Academy of Pediatrics recommend against mothers living with HIV breastfeeding. The CDC notes that women in the U.S, have access to clean water and infant formula,
“After giving birth, the mom should feed the baby using a bottle instead of breastfeeding,” agrees Kire Stojkovski, M.D., of the Farr Institute in West Des Moines, Iowa. “This will reduce the chances of the baby suffering from the disease since HIV can be transmitted through breastfeeding.” Stojkovski also says a pregnant women should eat healthy food.
Clinicians advises women to attend the antenatal period.
“During delivery, your caregiver will give you options depending on the viral load,” Probst says.
A panel of outside experts update the guidelines for antiretroviral drugs during pregnancy and interventions to reduce perinatal transmission late last year. Here are some highlights of the summary of the changes to the guidelines posted on the Hiv.gov:
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More